Ludwig Cancer Research

Toward Integration of Molecular Measures and Artificial Intelligence-Based Assessments With Clinical End Points in Inflammatory Bowel Disease

Reinisch W. et al, (2026), Gastroenterology, 170, 686 - 703

Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS–chemokine–myeloid axis

Beernaert B. et al, (2026), Science Advances, 12

Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B

Kalafateli M. et al, (2026), Clinical Gastroenterology and Hepatology, 24, 701 - 712.e8

The Role of Fibroblast–Epithelial Cross-Talk on the Distribution of Distinct Fibroblast Phenotypes in the Intestinal Crypt

Atkinson G. et al, (2026), Bulletin of Mathematical Biology, 88

comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders

Shen Y. et al, (2026), Cell Stem Cell, 33, 421 - 437.e7

Self-supervised Monocular Depth and Pose Estimation for Endoscopy with Latent Priors.

Xu Z. et al, (2026), IEEE transactions on medical imaging, PP

Rapid and durable recovery of immune effector cells in myelofibrosis patients treated with momelotinib.

Makker J. et al, (2026), Haematologica, 111, 1096 - 1099

Discrete genetic effects of VHL and PBRM1 inactivation co-operate to disrupt epithelial homeostasis and promote ccRCC

Kurlekar S. et al, (2026)

Response to Comments on ‘Hepatitis B Virus ( HBV ) Treatment Eligibility in the UK : Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines’

Campbell C. et al, (2026), Journal of Viral Hepatitis, 33

When, which and how to switch: Navigating JAK inhibitors in myelofibrosis

O'Sullivan J. et al, (2026), British Journal of Haematology, 208, 437 - 441

ACE2 inhibition ELISA is an effective surrogate for SARS-CoV-2 live virus neutralisation

Tipton T. et al, (2026), Vaccine, 72, 128123 - 128123

DNA methyltransferase inhibitors in oncology: clinical progress, limitations and future directions.

Michael DC. and Mehdipour P., (2026), Epigenomics, 1 - 29

JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms.

Kealy D. et al, (2026), Leukemia

Restoring Function to a Variant of p53 in Solid Tumors.

Lu X., (2026), The New England journal of medicine, 394, 922 - 925

Ancestry and somatic profile indicate acral melanoma origin and prognosis.

Basurto-Lozada P. et al, (2026), Nature

The RNA-binding protein SRSF3 controls epicardial formation by regulating splicing and proliferation

Lupu I-E. et al, (2026), Development

SAGA/ATAC complexes sustain aberrant chromatin regulation and promote tumorigenesis in diffuse midline glioma.

Richard RU. et al, (2026)

The aryl hydrocarbon receptor: structure, signaling, physiology and pathology

Coumoul X. et al, (2026), Signal Transduction and Targeted Therapy, 11

A CK2-FBXW11 kinase-E3 ubiquitin ligase cascade is a metabolic sensor regulating Tryptophan 2,3-dioxygenase stability

Thielen AS. et al, (2026)

Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studies

Danysz M. et al, (2026), Clinical Microbiology and Infection, 32, 41 - 55

Search results

Showing results for